ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,584.54
      -0.88%
      US Tech 100
      19,681.20
      -2.17%
      Dow Jones
      39,753.75
      0.08%
      Brent Oil
      85.29
      0.21%
      Bitcoin
      57,197.31
      -0.27%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. NGM Biopharmaceuticals Inc (NGM)

      7. NGM Biopharmaceuticals Inc (NGM) News

      NGM

      NGM Biopharmaceuticals (NGM)

      NGM Biopharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:NGM
      DateTimeSourceHeadlineSymbolCompany
      12:21PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
      06/07/20214:50PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NGMNGM Biopharmaceuticals Inc
      06/07/20218:00AMGlobeNewswire Inc.NGM Bio to Present at Two Upcoming Investor ConferencesNASDAQ:NGMNGM Biopharmaceuticals Inc
      05/24/20217:00AMGlobeNewswire Inc.NGM Bio Reports Topline Results from 24-Week Phase 2b ALPINE 2/3 Study of Aldafermin in NASHNASDAQ:NGMNGM Biopharmaceuticals Inc
      05/23/20216:00PMGlobeNewswire Inc.NGM Bio to Host Conference Call to Discuss Topline Results from 24-Week Phase 2b ALPINE 2/3 Study of Aldafermin in NASHNASDAQ:NGMNGM Biopharmaceuticals Inc
      05/06/20214:29PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NGMNGM Biopharmaceuticals Inc
      05/06/20214:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NGMNGM Biopharmaceuticals Inc
      05/06/20214:05PMGlobeNewswire Inc.NGM Bio Provides Business Highlights and Reports First Quarter 2021 Financial ResultsNASDAQ:NGMNGM Biopharmaceuticals Inc
      05/04/20214:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NGMNGM Biopharmaceuticals Inc
      04/28/20214:39PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NGMNGM Biopharmaceuticals Inc
      04/28/20214:37PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NGMNGM Biopharmaceuticals Inc
      04/28/20214:27PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NGMNGM Biopharmaceuticals Inc
      04/28/20214:15PMGlobeNewswire Inc.NGM Announces Nomination of Roger M. Perlmutter for Election to Its Board of DirectorsNASDAQ:NGMNGM Biopharmaceuticals Inc
      04/13/20216:57PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NGMNGM Biopharmaceuticals Inc
      03/15/20214:54PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:NGMNGM Biopharmaceuticals Inc
      03/10/20215:58PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NGMNGM Biopharmaceuticals Inc
      03/04/20214:05PMGlobeNewswire Inc.NGM Bio Provides Business Highlights and Reports Fourth Quarter and Full Year 2020 Financial ResultsNASDAQ:NGMNGM Biopharmaceuticals Inc
      03/02/20215:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NGMNGM Biopharmaceuticals Inc
      03/02/20218:00AMGlobeNewswire Inc.NGM Bio Initiates Expansion of Ongoing Phase 1b Proof-of-Concept Study of NGM120 in Patients with Metastatic Pancreatic Cance...NASDAQ:NGMNGM Biopharmaceuticals Inc
      02/25/20218:00AMGlobeNewswire Inc.NGM Bio to Present at the Cowen 41st Annual Health Care ConferenceNASDAQ:NGMNGM Biopharmaceuticals Inc
      02/16/20212:54PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NGMNGM Biopharmaceuticals Inc
      02/12/20216:28PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NGMNGM Biopharmaceuticals Inc
      02/09/20218:00AMGlobeNewswire Inc.NGM Bio Announces Upcoming Oral Presentation of Phase 1 Study of NGM621 in Patients with Geographic Atrophy at Angiogenesis, ...NASDAQ:NGMNGM Biopharmaceuticals Inc
      02/03/20214:48PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NGMNGM Biopharmaceuticals Inc
      01/12/20214:05PMGlobeNewswire Inc.NGM Bio Outlines 2021 Strategic Priorities Across Its Three Therapeutic Area Portfolios, Including Liver and Metabolic Diseas...NASDAQ:NGMNGM Biopharmaceuticals Inc
      01/06/20214:25PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NGMNGM Biopharmaceuticals Inc
      01/06/20214:24PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:NGMNGM Biopharmaceuticals Inc
      01/06/20215:04AMTipRanksNGM Bio Prices $125M Share Offering; Stock Falls 4%NASDAQ:NGMNGM Biopharmaceuticals Inc
      01/05/20219:54PMGlobeNewswire Inc.NGM Bio Announces Pricing of Upsized $125.0 Million Public Offering of Common StockNASDAQ:NGMNGM Biopharmaceuticals Inc
      01/04/20214:11PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:NGMNGM Biopharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:NGM